missing translation for 'onlineSavingsMsg'
Learn More
  1. Home
  2. Products
  3. Research and Clinical Diagnostic Tests and Controls
  4. Flu and Virus Testing
  5. Multiplex COVID Testing Kits
  6. 30280603

MP Biomedicals Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card

Product Code. 30280603 Shop All MP Biomedicals Products
Click to view available options
:
SARS-CoV-2 and Ifnluence Duo
This item is not returnable. View return policy

Product Code. 30280603

Brand: MP Biomedicals 07AG6020FL

Please to purchase this item. Need a web account? Register with us today!

Este artículo no se puede devolver. Vea la política de devoluciones

Descripción

SARS-CoV-2 Ag+Flu A/Flu B Rapid Test is a one-step in vitro test based on immunochromatography.

  • Rapid SARS-CoV-2/Influenza A+B Antigen Duo Test Card is an immunochromatographic lateral flow device that employs the principle of double antibody sandwich method.
  • Anti-SARS-CoV-2, anti-influenza A and anti-influenza B antibodies are immobilized on the nitrocellulose membrane respectively, as three individual test lines (CoV line, Flu A line and Flu B line) in the test window of the test device.
  • When the specimen is added, it migrates by capillary diffusion through the strip to re-hydrate the gold conjugate complexes.
  • If present at or above the limit of detection, viral antigens will react with the gold conjugate complexes to form particles, which will continue to migrate along the strip until the Test Zone (T) where they are captured by the immobilized anti-SARS-CoV-2 or anti-influenza A or anti-influenza B antibodies to form a visible red line, which indicates positive test results.
  • Absence of this colored band in the test window indicates a negative test result.
  • The gold conjugate complexes will continue to migrate alone until being captured by immobilized antibody in the Control Zone (C) to form a red line, which indicates the validity of the test.
  • CE marked
  • For professional use only
  • Accurate Result within 15 to 20 minutes
  • One-step procedure
  • No equipment needed
  • No cross-reaction
  • High sensitivity, specificity, and accuracy
  • This test is only to be used by professional medical staff, not for home testing. It cannot be used alone as the basis for the diagnosis and exclusion of cases.

Especificaciones

CE Marker Self-declared
Clia Complexity Not Applicable
Detectable Analytes SARS-CoV-2, Influenza A and Influenza B Nucleoprotein Antigens
Detection Method Immunochromatographic lateral flow
DoA Calibrators No
Format Test card
Sample Type Human nasal swabs, Human nasopharyngeal swabs, Human oropharyngeal swabs
Sensitivity SARS-CoV-2: 1.3 x 102 TCID{50}/mL, Influenza A: 1.78 x 102 TCID{50}/mL, Influenza B: 1.17 x 103 TCID{50}/mL
Type Rapid Test
Disposable Single-use
For Use With (Application) Rapid and qualitative determination of SARS-CoV-2, Influenza type A and type B viral antigen in nasal swabs, nasopharyngeal swabs or oropharyngeal swabs
Specificity SARS-CoV-2: 99.16% (95% CI: 98.49% ~ 99.83%) Influenza A: 98.69% (95% CI: 97.42% ~ 99.97%) Influenza B: 99.37% (95% CI: 98.50% ~ 100%)
Form Ready-to-Use (RTU)
Mostrar más Mostrar menos
Corrección del contenido de un producto

Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.

Título del producto

Al hacer clic en Enviar, acepta que Fisher Scientific se ponga en contacto con usted en relación con los comentarios que ha proporcionado en este formulario. No compartiremos su información para ningún otro fin. Toda la información de contacto proporcionada se mantendrá de acuerdo con nuestra Política de Privacidad. Política de privacidad.

Gracias por ayudarnos a mejorar nuestra web. Su comentario ha sido enviado